StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 762.00
-4.00 (-0.52%)
Aug 27, 2026, 1:14 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 7.71 billion as of August 26, 2026. Its market cap has decreased by -25.24% in one year.
Market Cap
7.71B
Enterprise Value
6.01B
Revenue
2.81B
Ranking
n/a
PE Ratio
49.91
Stock Price
762.00
ChartMarket Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 7.71B, a decrease of -63.54%. That is a compound annual growth rate of -17.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 7.71B | -3.40% |
| Dec 30, 2025 | 7.99B | -39.54% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nano Holdings | 9.21B |
| CellSeed | 9.15B |
| K Pharma,Inc. | 9.12B |
| Kidswell Bio | 9.05B |
| Carna Biosciences | 8.86B |
| OncoTherapy Science | 8.57B |
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.07B |